183 related articles for article (PubMed ID: 37057209)
1. ZNF460-regulated COMMD7 Promotes Acute Myeloid Leukemia Proliferation Via the NF-κB Signaling Pathway.
Shao X; Zhong L; Chu X; Wan P; Chen S; Zhou Z; Zhang H; Wang M; Liu B
Int J Med Sci; 2023; 20(4):520-529. PubMed ID: 37057209
[TBL] [Abstract][Full Text] [Related]
2. ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth.
Zheng L; Liang P; Li J; Huang XB; Liu SC; Zhao HZ; Han KQ; Wang Z
PLoS One; 2012; 7(9):e45412. PubMed ID: 23049798
[TBL] [Abstract][Full Text] [Related]
3. COMMD7 is correlated with a novel NF-κB positive feedback loop in hepatocellular carcinoma.
Zheng L; Deng CL; Wang L; Huang XB; You N; Tang YC; Wu K; Liang P; Mi N; Li J
Oncotarget; 2016 May; 7(22):32774-84. PubMed ID: 27129158
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of microRNA-125b inhibits human acute myeloid leukemia cells invasion, proliferation and promotes cells apoptosis by targeting NF-κB signaling pathway.
Wang Y; Tang P; Chen Y; Chen J; Ma R; Sun L
Biochem Biophys Res Commun; 2017 Jun; 488(1):60-66. PubMed ID: 28478034
[TBL] [Abstract][Full Text] [Related]
5. COMMD7 as a novel NEMO interacting protein involved in the termination of NF-κB signaling.
Esposito E; Napolitano G; Pescatore A; Calculli G; Incoronato MR; Leonardi A; Ursini MV
J Cell Physiol; 2016 Jan; 231(1):152-61. PubMed ID: 26060140
[TBL] [Abstract][Full Text] [Related]
6. WWP2 binds to NKRF, enhances the NF-κB signaling, and promotes malignant phenotypes of acute myeloid leukemia cells.
Wang H; Lian X; Wang K; Wang S
Biochem Cell Biol; 2024 Feb; 102(1):85-95. PubMed ID: 37921219
[TBL] [Abstract][Full Text] [Related]
7. IL-33-dependent NF-κB activation inhibits apoptosis and drives chemoresistance in acute myeloid leukemia.
Yan M; Chen X; Ye Q; Li H; Zhang L; Wang Y
Cytokine; 2024 Aug; 180():156672. PubMed ID: 38852492
[TBL] [Abstract][Full Text] [Related]
8. High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia.
Li K; Chen L; Zhang H; Wang L; Sha K; Du X; Li D; Zheng Z; Pei R; Lu Y; Tong H
Aging (Albany NY); 2021 Apr; 13(8):11988-12006. PubMed ID: 33891561
[TBL] [Abstract][Full Text] [Related]
9. Myeloid malignancies with chromosome 5q deletions acquire a dependency on an intrachromosomal NF-κB gene network.
Fang J; Barker B; Bolanos L; Liu X; Jerez A; Makishima H; Christie S; Chen X; Rao DS; Grimes HL; Komurov K; Weirauch MT; Cancelas JA; Maciejewski JP; Starczynowski DT
Cell Rep; 2014 Sep; 8(5):1328-38. PubMed ID: 25199827
[TBL] [Abstract][Full Text] [Related]
10. ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Grosjean-Raillard J; Tailler M; Adès L; Perfettini JL; Fabre C; Braun T; De Botton S; Fenaux P; Kroemer G
Oncogene; 2009 Feb; 28(8):1099-109. PubMed ID: 19079347
[TBL] [Abstract][Full Text] [Related]
11. miR-29b-3p suppresses the malignant biological behaviors of AML cells via inhibiting NF-κB and JAK/STAT signaling pathways by targeting HuR.
Tang YJ; Wu W; Chen QQ; Liu SH; Zheng ZY; Cui ZL; Xu JP; Xue Y; Lin DH
BMC Cancer; 2022 Aug; 22(1):909. PubMed ID: 35986311
[TBL] [Abstract][Full Text] [Related]
12. Aurora A and NF-κB Survival Pathway Drive Chemoresistance in Acute Myeloid Leukemia via the TRAF-Interacting Protein TIFA.
Wei TW; Wu PY; Wu TJ; Hou HA; Chou WC; Teng CJ; Lin CR; Chen JM; Lin TY; Su HC; Huang CF; Yu CR; Hsu SL; Tien HF; Tsai MD
Cancer Res; 2017 Jan; 77(2):494-508. PubMed ID: 28069801
[TBL] [Abstract][Full Text] [Related]
13. Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML.
Volk A; Li J; Xin J; You D; Zhang J; Liu X; Xiao Y; Breslin P; Li Z; Wei W; Schmidt R; Li X; Zhang Z; Kuo PC; Nand S; Zhang J; Chen J; Zhang J
J Exp Med; 2014 Jun; 211(6):1093-108. PubMed ID: 24842373
[TBL] [Abstract][Full Text] [Related]
14. COMMD7 activates CXCL10 production by regulating NF-κB and the production of reactive oxygen species.
You N; Li J; Huang X; Wu K; Tang Y; Wang L; Li H; Mi N; Zheng L
Mol Med Rep; 2018 May; 17(5):6784-6788. PubMed ID: 29532873
[TBL] [Abstract][Full Text] [Related]
15. Aberrant nuclear factor-kappa B activity in acute myeloid leukemia: from molecular pathogenesis to therapeutic target.
Zhou J; Ching YQ; Chng WJ
Oncotarget; 2015 Mar; 6(8):5490-500. PubMed ID: 25823927
[TBL] [Abstract][Full Text] [Related]
16. Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival.
Kapelko-Słowik K; Urbaniak-Kujda D; Wołowiec D; Jaźwiec B; Dybko J; Jakubaszko J; Słowik M; Kuliczkowski K
Postepy Hig Med Dosw (Online); 2013 Jun; 67():553-9. PubMed ID: 23752607
[TBL] [Abstract][Full Text] [Related]
17. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species.
Jin Y; Lu Z; Ding K; Li J; Du X; Chen C; Sun X; Wu Y; Zhou J; Pan J
Cancer Res; 2010 Mar; 70(6):2516-27. PubMed ID: 20215516
[TBL] [Abstract][Full Text] [Related]
18. [Role of NF-κB inhibitor in Acute Myeloid Leukemia].
Wang WL; Xu QZ; Mu XH; Wang L; Zhang LY; Xu J; Gao YD; Cheng T; Yuan WP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1622-1626. PubMed ID: 28024466
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor-kappaB signaling: a contributor in leukemogenesis and a target for pharmacological intervention in human acute myelogenous leukemia.
Reikvam H; Olsnes AM; Gjertsen BT; Ersvar E; Bruserud Ø
Crit Rev Oncog; 2009; 15(1-2):1-41. PubMed ID: 20136626
[TBL] [Abstract][Full Text] [Related]
20. CaMKIIγ regulates the viability and self-renewal of acute myeloid leukaemia stem-like cells by the Alox5/NF-κB pathway.
Cheng JH; Zhang WJ; Zhu JF; Cui D; Song KD; Qiang P; Mei CZ; Nie ZC; Ding BS; Han Z; Ding ZE; Zheng WW
Int J Lab Hematol; 2021 Aug; 43(4):699-706. PubMed ID: 33369192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]